|
|
 |
|
Viewing report
|
|
|
|
Company Financials: InterMune, Inc.
Datamonitor, Jan 2010
The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .
Scope
- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation
- Provides key ratios
- Includes information on revenue distribution by business segments and geographies
Highlights of this title
InterMune is a biotechnology company focused on developing and commercializing therapies in pulmonology and hepatology. The company currently markets Actimmune (interferon gamma-1b) for the treatment of severe, malignant osteopetrosis and chronic granulomatous disease.
Key reasons to purchase this title
- Includes information on revenue distribution by business segments and geographies
- Understand the financial evolution of the company over the last five years.
- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization
Customers who bought this item also bought
Company Financials: Flamel Technologies
Company Financials: Zimmer Holdings, Inc.
Company Financials: Medtronic, Inc.
Company Financials: Candela Corporation
Company Financials: Labopharm Inc.
Company Financials: Eli Lilly and Company
Company Financials: Bristol-Myers Squibb Company
Company Financials: Arqule, Inc.
Company Financials: Biogen Idec, Inc.
Company Financials: Genzyme Corporation
|
|
|
|
